These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 6497974

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Changes in the norms governing practices for the manufacture of pharmaceutical products: implications for the MERCOSUR].
    Temprano G, Prats S, Bregni C.
    Boll Chim Farm; 1998 Nov; 137(10):426-38. PubMed ID: 9880947
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization.
    World Health Organ Tech Rep Ser; 2005 Nov; 929():1-142, backcover. PubMed ID: 16353684
    [Abstract] [Full Text] [Related]

  • 7. Merck: committed to access to medicines for patients throughout the world.
    Gilmartin RV.
    N J Med; 2000 Nov; 97(11):27-9. PubMed ID: 11103598
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2008 Nov; (948):1-138. PubMed ID: 18557474
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intended use of reference products & WHO International Standards/Reference Reagents in the development of similar biological products (biosimilars).
    Thorpe R, Wadhwa M.
    Biologicals; 2011 Sep; 39(5):262-5. PubMed ID: 21880508
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA.
    Food Drug Law J; 1997 Sep; 52(1):67-82. PubMed ID: 10346711
    [No Abstract] [Full Text] [Related]

  • 15. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2006 Sep; 937():1-461, back cover. PubMed ID: 16836287
    [Abstract] [Full Text] [Related]

  • 16. GMPs vs GCPs: manufacturing and compounding definitions.
    Allen LV.
    Int J Pharm Compd; 2013 Sep; 17(5):356. PubMed ID: 24459778
    [No Abstract] [Full Text] [Related]

  • 17. [Technicoscientific evolution and current direction of the standards regulating drug registration in Italy and in the European Economic Community].
    Battaglino G.
    Boll Chim Farm; 1978 Jun; 117(6):313-24. PubMed ID: 743380
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Various aspects of the significance of government control in drug supply].
    Teijgeler CA, Samsom RJ.
    Pharm Weekbl; 1969 Jun 27; 104(26):539-49. PubMed ID: 5788999
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.